L-Ornithine L-Aspartate 10mL Infusion

L-Ornithine L-Aspartate Infusion 10mL contains L-ornithine L-aspartate, a liver-support medicine used in selected patients with raised ammonia or hepatic encephalopathy related to liver disease. L-ornithine L-aspartate supports ammonia detoxification by providing substrates involved in the urea cycle and glutamine synthesis, which can help reduce excess ammonia in some patients.
L-Ornithine L-Aspartate Infusion 10mL is given by IV infusion by healthcare professionals. The infusion rate and dilution should follow the prescribed protocol. Monitoring focuses on mental state, ammonia-related symptoms, kidney function, and tolerability.
L-ornithine L-aspartate provides amino-acid substrates that support ammonia conversion through urea-cycle and glutamine-related pathways.
Possible effects include nausea, vomiting, abdominal discomfort, diarrhea, and infusion-site discomfort. Seek review for worsening confusion, severe vomiting, allergic reaction, or reduced urination.
Review severe kidney impairment, advanced liver disease status, dehydration, electrolyte imbalance, active infection, gastrointestinal bleeding, constipation, pregnancy, breastfeeding, and current hepatic encephalopathy medicines.
Adjunctive management of hyperammonemia or hepatic encephalopathy related to liver disease when L-ornithine L-aspartate infusion is prescribed.
May help lower ammonia burden and support improvement in encephalopathy symptoms as part of broader liver-care management.
L-Ornithine L-Aspartate Infusion 10mL is used as supportive treatment for raised ammonia or hepatic encephalopathy when prescribed.
No. It may be used alongside standard treatment depending on the clinician's plan.
Severe kidney impairment can affect nitrogen handling and may change suitability or dosing.
Confusion, sleepiness, tremor or asterixis, ammonia-related features, vomiting, and overall liver status are monitored.
No. It is used for specific ammonia-related liver indications under medical supervision.
L ornithine L aspartate infusion, Hepatic encephalopathy support, Ammonia lowering therapy, Liver disease confusion, Urea cycle support, Hyperammonemia management, AR: L-Ornithine L-Aspartate Infusion حقن, FR: L-Ornithine L-Aspartate Infusion, PT: L-Ornithine L-Aspartate Infusion injeção, ES: L-Ornithine L-Aspartate Infusion inyección, RU: L-Ornithine L-Aspartate Infusion инъекция, ID: L-Ornithine L-Aspartate Infusion injeksi, VI: L-Ornithine L-Aspartate Infusion thuốc tiêm, MS: L-Ornithine L-Aspartate Infusion suntikan, TL: L-Ornithine L-Aspartate Infusion iniksyon, ZH-SG: L-Ornithine L-Aspartate Infusion 注射剂
International B2B Enquiry
Send a structured B2B enquiry for L-Ornithine L-Aspartate 10mL Infusion under Liver Care. Global Medicines Export helps international buyers review product information, pack details, quantity requirements, destination-market needs, quotation support and export documentation coordination from India.
Product name, required strength or pack, expected quantity, destination country, buyer type and preferred manufacturer if any.
Availability, quotation support, documentation expectations and shipment-ready order communication can be reviewed before confirmation.
Commercial invoice, packing information, manufacturer details, batch details and supporting documents where applicable and available.
Product availability, quotation, and documentation support are coordinated for international B2B enquiries.
L-Ornithine L-Aspartate 10mL Infusion